Analyzing the synthesis route of 17217-57-1

17217-57-1, 17217-57-1 4,4′-Dimethoxy-2,2′-bipyridine 2733927, acatalyst-ligand compound, is more and more widely used in various.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.17217-57-1,4,4′-Dimethoxy-2,2′-bipyridine,as a common compound, the synthetic route is as follows.

General procedure: [Rh(bpy)2(4,4′-dmobpy)](PF6)3 was prepared as above but using cis-[Rh(bpy)2(OTf)2](OTf) (102 mg, 0.118 mmol) and4,4′-dimethoxy-2,2′-bipyridine (29.3 mg, 0.135 mmol) in 10 mL ethanol and refluxing for 30 min. Yield of analytically pure,off-white product (110 mg, 0.100 mmol), 84percent. Anal. Calcd forC32H28N6RhO4P3F18: C, 34.99; H, 2.57; N, 7.65. Found: C, 35.00; H,2.58; N, 7.55. 1H NMR (d6-DMSO, 400 MHz): d (ppm) aromaticprotons [9.04 (d, J = 8.23 Hz, 4H), 8.67 (d, J = 2.49 Hz, 2H), 8.57 (q,J = 7.95 Hz, 4H), 7.91 (d, J = 5.74 Hz, 2H), 7.84 (t, J = 8.18 Hz, 2H),7.79 (q, J = 5.82 Hz, 4H), 7.57 (d, J = 6.83 Hz, 2H), 7.30 (dd,J = 6.34 Hz, 2H)], 4.08 (s, 6H, OCH3). 13C NMR (d6-DMSO,100 MHz): d (ppm) aromatic carbons [169.8, 155.6, 154.6, 154.5,151.2, 151.0, 150.7, 143.0, 130.4, 126.7, 120.6, 115.6, 113.7], 57.7(OCH3).

17217-57-1, 17217-57-1 4,4′-Dimethoxy-2,2′-bipyridine 2733927, acatalyst-ligand compound, is more and more widely used in various.

Reference£º
Article; Amarante, Daniel; Cherian, Cheryl; Megehee, Elise G.; Inorganica Chimica Acta; vol. 461; (2017); p. 239 – 247;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

Simple exploration of 17217-57-1

17217-57-1, As the paragraph descriping shows that 17217-57-1 is playing an increasingly important role.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.17217-57-1,4,4′-Dimethoxy-2,2′-bipyridine,as a common compound, the synthetic route is as follows.

General procedure: [Cu-(MeCN)4]PF6 (74 mg, 0.20 mmol) was added to TolBINAP(135 mg, 0.20 mmol) in 2 mL CH2Cl2. Then, bpy (31 mg, 0.20mmol) was added. The yellow reaction mixture was stirred for90 minutes at room temperature. Diethyl ether (25 mL) wasadded to the solution to precipitate the product as a yellowsolid, which was filtered and dried in vacuum.

17217-57-1, As the paragraph descriping shows that 17217-57-1 is playing an increasingly important role.

Reference£º
Article; Nishikawa, Michihiro; Tsuji, Masakata; Ohishi, Tomoyuki; Tsubomura, Taro; Bulletin of the Chemical Society of Japan; vol. 90; 7; (2017); p. 798 – 800;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

Brief introduction of 17217-57-1

17217-57-1, The synthetic route of 17217-57-1 has been constantly updated, and we look forward to future research findings.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.17217-57-1,4,4′-Dimethoxy-2,2′-bipyridine,as a common compound, the synthetic route is as follows.

General procedure: [Cu-(MeCN)4]PF6 (74 mg, 0.20 mmol) was added to TolBINAP(135 mg, 0.20 mmol) in 2 mL CH2Cl2. Then, bpy (31 mg, 0.20mmol) was added. The yellow reaction mixture was stirred for90 minutes at room temperature. Diethyl ether (25 mL) wasadded to the solution to precipitate the product as a yellowsolid, which was filtered and dried in vacuum.

17217-57-1, The synthetic route of 17217-57-1 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Nishikawa, Michihiro; Tsuji, Masakata; Ohishi, Tomoyuki; Tsubomura, Taro; Bulletin of the Chemical Society of Japan; vol. 90; 7; (2017); p. 798 – 800;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

Downstream synthetic route of 17217-57-1

17217-57-1, The synthetic route of 17217-57-1 has been constantly updated, and we look forward to future research findings.

17217-57-1, 4,4′-Dimethoxy-2,2′-bipyridine is a catalyst-ligand compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

General procedure: Heteroleptic iridium 4xy were synthesized in a two-step procedure[42,43]. In the first step, chloro-bridged dimer was synthesized by charging a two-necked reaction flask with magnetic stir bar, iridium(III) chloride (1 equiv), ligand (2.26 equiv), and a 2:1 v:v mixture of 2-methoxyethanol/water. The mixture was degased with Ar (via Ar bubbling) and heated under reflux at 120 ¡ãC with constant stirring overnight. The reaction mixture cooled to room temperature and filtered. The precipitate was washed with water (3×10 mL), dried in air and taken onto the second step without further purification unless noted. In the second step, the chloro bridging dimer (1 equiv), bipyridyl ligand (2.2 equiv) and ethylene glycol were placed in a two-necked flask and then flushed with Ar. The mixture was heated at 150 ¡ãC for 15 h and then cooled. The cooled reaction mixture was washed hexane (3 10 mL) and mixture was heated to 85 ¡ãC for 5 min to remove residual hexane. Aqueous ammonium hexafluorophosphate (sat. solution) was added to the reaction mixture causing the iridium-PF6 salt to precipitate,which was filtered, dried and recrystallized (acetone/ether).

17217-57-1, The synthetic route of 17217-57-1 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Singh, Anuradha; Teegardin, Kip; Kelly, Megan; Prasad, Kariate S.; Krishnan, Sadagopan; Weaver, Jimmie D.; Journal of Organometallic Chemistry; vol. 776; (2015); p. 51 – 59;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

Some tips on 17217-57-1

As the paragraph descriping shows that 17217-57-1 is playing an increasingly important role.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.17217-57-1,4,4′-Dimethoxy-2,2′-bipyridine,as a common compound, the synthetic route is as follows.

General procedure: 4,4?-Dmo-2,2?-bpy (0.22 g, 1 mmol) was placed in oneof the arms of a branched tube [32], and zinc(II) acetatedihydrate (0.11 g, 0.5 mmol) and potassium thiocyanate(0.10 g, 1 mmol) were placed in the other arm. Ethanoland water in a ratio of 3:2 were carefully added to fill botharms. The tube was then sealed and the ligand-containingarm was immersed in a bath at 60¡ãC, whereas the otherwas maintained at ambient temperature. After 1 day, crystalsthat were deposited in the cooler arm were filtered off,washed with mother liquid, and dried in air, yield: 0.18 g,59percent.

As the paragraph descriping shows that 17217-57-1 is playing an increasingly important role.

Reference£º
Article; Marandi, Farzin; Moeini, Keyvan; Rudbari, Hadi Amiri; Zeitschrift fur Naturforschung, B: Chemical Sciences; vol. 71; 9; (2016); p. 959 – 965;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI